Clinical Trial

Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial

Study acronym: CROSSUVA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2025 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the effect of cronic GSE intake in crosstraining may have a favorable impact on biochemical markers, recovery, and performance.
Trial Details
NCT Number NCT07106281
Lead Sponsor Universidad de Granada
Collaborators: Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.
Conditions Performance
Enrollment 30 participants
Start Date 2025-09-01
Primary Completion 2025-12-20 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-06